Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the class of quinoline carboxylic acids. It is structurally characterized by a quinoline core substituted with hydroxy and hydroxyethyl groups and a carboxylic acid moiety. The compound is primarily studied as an experimental agent and has not been approved for clinical use. Its mechanism of action is presumed to involve metal ion chelation due to the presence of both hydroxyl and carboxyl functional groups on the quinoline ring system, similar to related compounds in this class[2][10]. No specific therapeutic indication or developer company has been established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 8-hydroxy-4-(1-hydroxyethyl)quinoline-2-carboxylic acid.